Selective antileukemia effect of stabilized nanohybrid vesicles based on cholesteryl succinyl silane

Biomaterials

Volumn 32, Issue 35, 2011, Pages 9300-9307

  Ma, Yan ^a   Dai, Zhifei ^a   Zha, Zhengbao ^a   Gao, Yanguang ^a   Yue, Xiuli ^a  

^a HARBIN INSTITUTE OF TECHNOLOGY   (China)

Author keywords

Active carriers; Cholesteryl derivative; Leukemia cells; Nanohybrid vesicles; Selective anticancer effects

Indexed keywords

ANTICANCER EFFECTS; ANTIPROLIFERATIVE EFFECT; BILAYER MEMBRANES; BLOOD CELLS; CANCER THERAPEUTICS; CHOLESTERYL DERIVATIVES; DOXORUBICIN; GUEST SPECIES; HIGH STABILITY; HYDROPHOBIC MOLECULES; LEUKEMIA CELLS; NANOHYBRIDS; SELF-ASSEMBLY TECHNIQUE; TOXIC SIDE EFFECTS;

BLOOD; CELLS; NANOSTRUCTURED MATERIALS; SOL-GEL PROCESS; TOXIC MATERIALS;

DISEASES;

ANTILEUKEMIC AGENT; CHOLESTERYL SUCCINYL SILANE; DOXORUBICIN; DRUG CARRIER; NANOPARTICLE; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BLOOD CELL; CELL ENCAPSULATION; CELL PROLIFERATION; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG RELEASE; DRUG SELECTIVITY; DRUG STABILITY; GEL; HUMAN; HUMAN CELL; HYDROPHOBICITY; LEUKEMIA CELL; PRIORITY JOURNAL; SYNTHESIS;

ANTINEOPLASTIC AGENTS; BLOOD CELLS; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; DOXORUBICIN; DRUG SCREENING ASSAYS, ANTITUMOR; HUMANS; HYDRODYNAMICS; HYDROGEN-ION CONCENTRATION; LEUKEMIA; LIPOSOMES; NANOPARTICLES; OCTOXYNOL; PARTICLE SIZE; SILANES; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; STATIC ELECTRICITY;

EID: 80053618518     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2011.08.043     Document Type: Article

References (28)

1. Robak T., Kasznicki M. Alkylating agents and nucleoside analogues in the treatment of B cell chronic lymphocytic leukemia. Leukemia 2002, 16:1015-1027.
2. Yang X.Q., Hong H., Grailer J.J., Rowland I.J., Javadi A., Hurley S.A., et al. cRGD-functionalized, DOX-conjugated, and Cu-64-labeled superparamagnetic iron oxide nanoparticles for targeted anticancer drug delivery and PET/MR imaging. Biomaterials 2011, 32:4151-4160.
3. Zhang H.J., Chen B.A., Jiang H., Wang C.L., Wang H.P., Wang X.M. A strategy for ZnO nanorod mediated multi-mode cancer treatment. Biomaterials 2011, 32:1906-1914.
4. Castelli F., Pitarresi G., Giammona G. Influence of different parameters on drug release from hydrogel systems to a biomembrane model. Evaluation by differential scanning calorimetry technique. Biomaterials 2000, 21:821-833.
5. Theiszova M., Jantova S., Letasiova S., Palou M., Cipak L. Cytotoxicity of hydroxyapatite, fluorapatite and fluor-hydroxyapatite: a comparative in vitro study. Neoplasma 2008, 55:312-316.
6. Liu L.H., Guo K., Lu J., Venkatraman S.S., Luo D., Ng K.C., et al. Biologically active core/shell nanoparticles self-assembled from cholesterol-terminated PEG-TAT for drug delivery across the blood-brain barrier. Biomaterials 2008, 29:1509-1517.
7. Ke H.T., Wang J.R., Dai Z.F., Jin Y.S., Qu E.Z., Xing Z.W., et al. Gold-nanoshelled microcapsules: a theranostic agent for ultrasound contrast imaging and photothermal therapy. Angew Chem Int Edit 2011, 50:3017-3021.
8. Yang S.J., Lin F.H., Tsai H.M., Lin C.F., Chin H.C., Wong J.M., et al. Alginate-folic acid-modified chitosan nanoparticles for photodynamic detection of intestinal neoplasms. Biomaterials 2011, 32:2174-2182.
9. Shen Y.Q., Jin E., Zhang B., Murphy C.J., Sui M., Zhao J., et al. Prodrugs forming high drug loading multifunctional nanocapsules for intracellular cancer drug delivery. J Am Chem Soc 2010, 132:4259-4265.
10. Liu X.M., Pramoda K.P., Yang Y.Y., Chow S.Y., He C.B. Cholesteryl-grafted functional amphiphilic poly(N-isopropylacrylamide-co-N-hydroxylmethylacrylamide): synthesis, temperaturesensitivity, self-assembly and encapsulation of a hydrophobic agent. Biomaterials 2004, 25:2619-2628.
11. Oba M., Miyata K., Osada K., Christie R.J., Sanjoh M., Li W.D., et al. Polyplex micelles prepared from omega-cholesteryl PEG-polycation block copolymers for systemic gene delivery. Biomaterials 2011, 32:652-663.
12. Boridy S., Takahashi H., Akiyoshi K., Maysinger D. The binding of pullulan modified cholesteryl nanogels to a beta oligomers and their suppression of cytotoxicity. Biomaterials 2009, 30:5583-5591.
13. Fariss M.W., Fortuna M.B., Everett C.K., Smith J.D., Trent D.F., Djuric Z. The selective antiproliferative effects of alpha-tocopheryl hemisuccinate and cholesteryl hemisuccinate on murine leukemia-cells result from the action of the intact compounds. Cancer Res 1994, 54:3346-3351.
14. Hudson S.P., Padera R.F., Langer R., Kohane D.S. The biocompatibility of mesoporous silicates. Biomaterials 2008, 29:4045-4055.
15. Katagiri K., Hashizume M., Ariga K., Terashima T., Kikuchi J. Preparation and characterization of a novel organic-inorganic nanohybrid "cerasome" formed with a liposomal membrane and silicate surface. Chem Eur J 2007, 13:5272-5281.
16. Dai Z.F., Tian W.J., Yue X.L., Zheng Z.Z., Qi J.J., Tamai N., et al. Efficient fluorescence resonance energy transfer in highly stable liposomal nanohybrid cerasome. Chem Commun 2009, 2032-2034.
17. Cao Z., Ma Y., Yue X.L., Li S.Z., Dai Z.F., Kikuchi J. Stabilized liposomal nanohybrid cerasomes for drug delivery applications. Chem Commun 2010, 46:5265-5267.
18. Ma Y., Dai Z.F., Gao Y.G., Cao Z., Zha Z.B., Yue X.L., et al. Liposomal architecture boosts biocompatibility of nanohybrid cerasomes. Nanotoxicology 2011, 10.3109/17435390.2010.546950.
19. Liang X.L., Yue X.L., Dai Z.F., Kikuchi J. Photoresponsive liposomal nanohybrid cerasomes. Chem Commun 2011, 47:4751-4753.
20. Jin Y.G., Xin R., Ai P., Chen D.W. Self-assembled drug delivery systems 2. cholesteryl derivatives of antiviral nucleoside analogues: synthesis, properties and the vesicle formation. Int J Pharmaceut 2008, 350:330-337.
21. Steinberg Y., Schroeder A., Talmon Y., Schmidt J., Khalfin R.L., Cohen Y., et al. Triggered release of aqueous content from liposome-derived sol-gel nanocapsules. Langmuir 2007, 23:12024-12031.
22. Ehrenberg M.S., Friedman A.E., Finkelstein J.N., Oberdorster G., McGrath J.L. The influence of protein adsorption on nanoparticle association with cultured endothelial cells. Biomaterials 2009, 30:603-610.
23. Ishimaru C., Yonezawa Y., Kuriyama I., Nishida M., Yoshida H., Mizushina Y. Inhibitory effects of cholesterol derivatives on DNA polymerase and topoisomerase activities, and human cancer cell growth. Lipids 2008, 43:373-382.
24. Djuric Z., Heilbrun L.K., Lababidi S., EverettBauer C.K., Fariss M.W. Growth inhibition of MCF-7 and MCF-1OA human breast cells by alpha-tocopheryl hemisuccinate, cholesteryl hemisuccinate and their ether analogs. Cancer Lett 1997, 111:133-139.
25. Lai M.Z., Duzgunes N., Szoka F.C. Effects of replacement of the hydroxyl group of cholesterol and a-tocopherol on the thermotropic behavior of phospholipid membranes. Biochemistry 1985, 24:1646-1653.
26. Mukherjee S., Maxfield F.R. Membrane domains. Annu Rev Cell Dev Biol 2004, 20:839-866.
27. Lillemeier B.F., Pfeiffer J.R., Surviladze Z., Wilson B.S., Davis M.M. Plasma membrane-associated proteins are clustered into islands attached to the cytoskeleton. Proc Natl Acad Sci U.S.A 2006, 103:18992-18997.
28. Katagiri K., Hamasaki R., Ariga K., Kikuchi J. Preparation and surface modifi{ligature}cation of novel vesicular nano-particle"cerasome" with liposomal bilayer and silicate surface. J Sol-gel Sci Techn 2003, 26:393-396.